Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions
Tasuku Terada(University of Ottawa), Jennifer L. Reed(Cincinnati Children's Hospital Medical Center), Matheus Hausen(University of Ottawa), Isabela Roque Marçal(University of Ottawa), Kimberley L. Way(Deakin University), Carley O’Neill(University of Ottawa), Paul Dorian(St. Michael's Hospital)
Cited by 16
Related Papers
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
|New England Journal of Medicine|2004|1.5k
Amiodarone to Prevent Recurrence of Atrial Fibrillation
|New England Journal of Medicine|2000|1.2k
MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
|Journal of Allergy and Clinical Immunology|2010|583